The 10th Ocular Diseases Drug Discovery Conference is scheduled for March 20-21, 2018 in San Diego, CA. We are excited to have representatives from the industry and academic sectors to discuss technologies and targets that are continually changing the way ocular diseases are treated. Drug delivery is always improving as we look at for better methods to penetrate anterior and posterior segments of the eye. Successes in gene therapy and regenerative medicine are proving to be interesting approaches to discuss in detail preclinically and clinically. We are inviting leading scientists, researchers, and experts to discuss and collaborate on combating various ocular diseases.
|Jerry Cagle |
Independent Pharmaceuticals Professional
Former VP, R&D, Alcon
|Carl Romano |
Executive Director, Ophthalmology
|Linda Zangwill |
UC San Diego
|Cristina Kenney |
Professor & Director, Ophthalmology Research
- Opening Keynote Session: Historical Perspective and State of the Industry
- Preclinical Development of Novel Technologies
- Translational Studies and Lessons Learned
- Panel: Ophthalmology Funding Environment
- Panel: Regulatory Challenges
- Partnering between Industry, Academia, and CROs to Advance Research
- Start-Up Showcase (Lunch Session)
- Closing Keynote Session: Predictions for Future
We hope to see you there!
The 2018 Advisory Committee
|2018 ADVISORY BOARD MEMBERS|
|Matthias Birkhoff, Aptar|
|Oscar Cuzzani, BioTime|
|Emmett Cunningham, Clarus Ventures|
|Rafal Farjo, EyeCRO LLC|
|Rangaramujam Kannan, John Hopkins University|
Amber Kempf at 626-256-6405 or amber.kempf [at] gtcbio.com
Trial Runners is an ophthalmology CRO providing biotech and pharmaceutical companies with clinical research management services. During the past 12 years, we have worked on over 61 global clinical studies researching innovative ways to manage or cure diseases related to the eye.
CBSET is a not-for-profit translational research institute specializing in the evaluation of drugs, biotherapeutics, combination products, and medical devices. We provide preclinical services including in-life testing, histopathology and regulatory consulting. Our GLP-compliant facilities host a multidisciplinary team of medical, scientific and regulatory experts who actively collaborate in getting novel technologies to market.
Absorption Systems is a nonclinical CRO specializing in ADMET services for drugs, biologics, and medical devices. Our ocular capabilities span from in vitro permeability to in vivo PK, toxicology, disease models, and devices. All animal studies are performed in our AAALAC-accredited, GLP-compliant, and NIH-assured vivarium located in San Diego, CA. We have experience with species such as rabbit, pig, dog, and sheep plus disease models including glaucoma, AMD, KCS, CNV, and more.
Powered Research, LLC is a preclinical CRO that specializes in non-GLP swine, rabbit, and rodent models in the ophthalmic space. With our extensive expertise and quick turn-around time, we’ve helped multiple ocular companies with their R&D needs. In addition to in-life studies, we provide full histology services in-house.
Viracor Eurofins provides clinical trial biomarker testing services with expertise in custom assay transfer, design and validation for phase I-IV trials. Our CAP/CLIA and NY state accredited laboratory has over 30 years of experience in molecular testing, immune response monitoring, vaccine safety/efficacy assessment, allergy and hypersensitivity testing.
Cancer Genetics Inc. (CGI; Nasdaq: CGIX) is a leader in enabling precision medicine in oncology from bench to bedside through the use of oncology biomarkers and molecular testing. CGI is developing a global footprint with locations in the US, India and China. The Company offers a comprehensive range of laboratory services that provide critical genomic and biomarker information. Its state-of-the-art reference labs are CLIA-certified and CAP-accredited in the US and have licensure from several states including New York State. CGI has established strong clinical research collaborations with major cancer centers such as Memorial Sloan Kettering, The Cleveland Clinic, Mayo Clinic, Keck School of Medicine at USC and the National Cancer Institute.